Reports of Guillain-Barre syndrome (GBS) have emerged during the Coronavirus disease 2019 (COVID-19) pandemic. An epidemiological and cohort study sought to investigate any causative association between COVID-19 infection and GBS. Early reports identified neurological symptoms of COVID-19 infection as fever, headache anosmia, and dysgeusia. Subsequently, COVID-19 infection has been associated with stroke, meningoencephalitis, acute disseminated encephalomyelitis, and Guillain-Barre syndrome (GBS). …